Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-25 Purchase | 2023-08-29 4:08 pm | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 4,000 | $2.76 | $11,040 | 135,638 (Direct) | View |
| 2023-08-14 Purchase | 2023-08-16 4:07 pm | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 3,000 | $2.86 | $8,580 | 134,578 (Direct) | View |
| 2023-03-23 Sale | 2023-03-27 4:05 pm | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 9,325 | $3.28 | $30,586 | 96,419 (Direct) | View |
| 2022-05-27 Purchase | 2022-05-31 4:06 pm | Cue Biopharma Inc. | CUE | Morich Frank Director | 28,000 | $3.75 | $105,000 | 28,000 (Direct) | View |
| 2022-05-23 Purchase | 2022-05-25 09:09 am | Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director | 205,000 | $3.4717 | $711,700 | 1,113,867 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 250,000 | $0 | 250,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 400,000 | $0 | 400,000 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 260,000 | $0 | 260,000 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 4:00 pm | N/A 2033-01-16 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | Garzone Pamela Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:01 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | Verheyen Patrick Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:00 pm | N/A 2034-01-01 | Cue Biopharma Inc. | CUE | Morich Frank Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:33 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 82,500 | $0 | 82,500 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:31 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 113,000 | $0 | 113,000 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:28 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 450,000 | $0 | 450,000 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:27 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:25 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 124,125 | $0 | 124,125 (Direct) | View |
| 2023-04-19 Option Award | 2023-04-21 4:15 pm | N/A 2033-04-18 | Cue Biopharma Inc. | CUE | Garzone Pamela Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-04-13 4:43 pm | N/A N/A | Cue Biopharma Inc. | CUE | Verheyen Patrick Director | 0 | $0 | 8,174 (Direct) | View |
| 2023-04-11 Option Award | 2023-04-13 4:42 pm | N/A 2033-04-10 | Cue Biopharma Inc. | CUE | Verheyen Patrick Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-03-23 Exercise | 2023-03-27 4:05 pm | N/A 2023-03-23 | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 9,682 | $0 | 96,419 (Direct) | View |
| 2023-03-23 Exercise | 2023-03-27 4:05 pm | N/A N/A | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 9,682 | $2.86 | 96,419 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:03 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | NASSHORN PATRICIA Chief Business Officer | 97,900 | $0 | 97,900 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:01 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 125,500 | $0 | 125,500 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:00 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 4:59 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 324,000 | $0 | 324,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 4:58 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 124,000 | $0 | 124,000 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 4:02 pm | N/A 2033-01-16 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
Ownership | 2023-01-19 4:01 pm | N/A N/A | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 0 | $0 | 137,230 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:11 pm | N/A 2033-01-02 | Cue Biopharma Inc. | CUE | Morich Frank Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:10 pm | N/A 2033-01-02 | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:09 pm | N/A 2033-01-02 | Cue Biopharma Inc. | CUE | HOWSON TAMAR D Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:08 pm | N/A 2033-01-02 | Cue Biopharma Inc. | CUE | Fletcher Aaron G.L. Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:08 pm | N/A 2033-01-02 | Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-08-21 Exercise | 2022-08-23 4:03 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 6,667 | $0 | 14,311 (Direct) | View |
| 2022-08-22 Tax Withholding | 2022-08-23 4:03 pm | N/A N/A | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 2,828 | $3.05 | 14,311 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 4:01 pm | N/A N/A | Cue Biopharma Inc. | CUE | Gray Cameron Director | 61,111 | $2.7 | 687,049 (Direct) | View |
| 2022-06-14 Tax Withholding | 2022-06-16 4:01 pm | N/A N/A | Cue Biopharma Inc. | CUE | Gray Cameron Director | 51,562 | $3.2 | 687,049 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 4:01 pm | 2015-06-15 2022-06-15 | Cue Biopharma Inc. | CUE | Gray Cameron Director | 61,111 | $0 | 687,049 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 5:31 pm | N/A N/A | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 16,668 | $0 | 103,638 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 5:31 pm | N/A N/A | Cue Biopharma Inc. | CUE | Suri Anish PRESIDENT AND CSO | 7,068 | $4.88 | 103,638 (Direct) | View |